Log In
Print
BCIQ
Print
Print this Print this
 

ALX-0751

  Manage Alerts
Collapse Summary General Information
Company Ablynx N.V.
DescriptionNanobody against an undisclosed target
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Merck KGaA


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today